About
Neurotronic develops Neuviant Multi-organ Denervation, an investigational therapy using catheter-delivered ethanol to target sympathetic nerves in the kidneys and liver to help control type 2 diabetes and hypertension.
Explore Neurotronic's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.